Palliative chemotherapy in recurrent carcinoma of the cervix: An audit of the use of ifosfamide and review of the literature

International Journal of Gynecological Cancer

Volumn 9, Issue 1, 1999, Pages 12-17

  Tutt, A N J ^a,b   Lodge, N ^a   Blake, P R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Carcinoma; Cervix; Chemotherapy; Ifosfamide; Palliation; Quality of life

Indexed keywords

IFOSFAMIDE;

ADENOCARCINOMA; ADULT; AGED; ALOPECIA; ARTICLE; BONE MARROW TOXICITY; BRAIN DISEASE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT CANCER; UTERINE CERVIX CARCINOMA; VOMITING;

EID: 0032972161     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1999.09824.x     Document Type: Article

References (23)

1. Thigpen JT, Vance R, Puneky L, Khansur T. Chemotherapy as a palliative treatment in carcinoma of the uterine cervix. Semin Oncol 1995; 22 (Suppl. 3): 16-24.
2. Stehman FB, Blessing JA, McGehee R, Barrett RJ. A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 1989; 7: 1892-5.
3. Thigpen T, Shingleton H, Homesley H, Lagasse L, Blessing J. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Cancer 1981; 48: 899-903.
4. Sutton GP, Blessing JA, Photopulos G, Berman ML, Homesley HD. Gynecologic Oncology Group experience with ifosfamide. Semin Oncol 1990; 17 (Suppl. 4): 6-10.
5. Coleman RE, Harper PG, Gallagher C et al. A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix. Cancer Chemother Pharmacol 1986; 18: 280-3.
6. Meanwell CA, Mould JJ, Blackledge G et al. Phase II study of ifosfamide in cervical cancer. Cancer Treat Rep 1986; 70: 727-30.
7. Hannigan EV, Dinh TV, Doherty MG. Ifosfamide with mesna in squamous carcinoma of the cervix: phase II results in patients with advanced or recurrent disease. Gynecol Oncol 1991; 43: 123-8.
8. Cervellino JC, Araujo CE, Pirisi C, Sanchez O, Brosto M, Rossi R. Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study. Cancer Chemother Pharmacol 1990; 26 (Suppl.): S1-3.
9. Thigpen T, Vance RB, Khansur T. Carcinoma of the uterine cervix: current status and future directions. Semin Oncol 1994; 21 (Suppl. 2): 43-54.
10. Hoskin PJ, Blake PR. Cisplatin, methotrexate and bleomycin (PMB) for carcinoma of the cervix: the influence of presentation and previous treatment upon response. Int J Gynecol Cancer 1991; 1: 75-80.
11. Murad AM, Triginelli SA, Ribalta JC. Phase II trial of bleomycin, ifosfamide, and carboplatin in metastatic cervical cancer. J Clin Oncol 1994; 12: 55-9.
12. Buxton EJ, Meanwell CA, Hilton C et al. Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer. J Natl Cancer Inst 1989; 81: 359-61.
13. Kumar L, Bhargava VL. Chemotherapy in recurrent and advanced cervical cancer [see comments]. Gynecol Oncol 1991; 40: 107-11.
14. Ramm K, Vergote IB, Kaern J, Trope CG. Bleomycinifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look. Gynecol Oncol 1992; 46: 203-7.
15. Tay SK, Lai FM, Soh LT, Ho TH, Ang PT, Au E. Combined chemotherapy using cisplatin, ifosfamide and bleomycin (PIB) in the treatment of advanced and recurrent cervical carcinoma. Aust NZJ Obstet Gynaecol 1992; 32: 263-6.
16. Omura GA, Blessing JA, Vaccarello L et al. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1997; 15: 165-71.
17. Meanwell CA, Blake AE, Kelly KA, Honigsberger L, Blackledge G. Prediction of ifosfamide/mesna associated encephalopathy. Eur J Cancer Clin Oncol 1986; 22: 815-9.
18. Omura GA. Chemotherapy for stage IVB or recurrent cancer of the uterine cervix. J Natl Cancer Inst Monogr 1996; 21: 123-6.
19. Adelstein DJ. Palliative chemotherapy for non-small cell lung cancer. Semin Oncol 1995; 22 (Suppl. 3): 35-9.
20. Curtin JP, Koonings PP, Gutierrez M, Schlaerth JB, Morrow CP. Ifosfamide-induced neurotoxicity. Gynecol Oncol 1991; 42: 193-6.
21. Meanwell C, Kelly K, Blackledge G. Avoiding ifosfamide/mesna encephalopathy. Lancet 1986; 2: 406.
22. Watkin SW, Husband DJ, Green JA, Warenius HM. Ifosfamide encephalopathy: a reappraisal. Eur J Cancer Clin Oncol 1989; 25: 1303-10.
23. Kupfer A, Aeschlimann C, Wermuth B, Cerny T. Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue. Lancet 1994; 343: 763-4.